Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
Clinical trial NCT00552149 · COMPLETED
Trial details
- NCT number
- NCT00552149
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2012-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.